 |
|
A fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrier
Joong Ho Bae, Joo Hyun Sohn, Hye Soon Lee, Hye Sun Park, Yil Sik Hyun, Tae Yeob Kim, Chang Soo Eun, Yong Cheol Jeon, Dong Soo Han
Clin Mol Hepatol. 2012;18(2):225-228. Published online 2012 Jun 26 DOI: https://doi.org/10.3350/cmh.2012.18.2.225
|
|
Citations to this article as recorded by
 Anti-rheumatic drug-induced hepatitis B virus reactivation and preventive strategies for hepatocellular carcinoma
Qiao Zhou, Qi Zhang, Kaiwen Wang, Ting Huang, Shaoping Deng, Yi Wang, Chunming Cheng
Pharmacological Research.2022; 178: 106181. CrossRef Effect of Low-Dose Corticosteroid Use on HBV Reactivation in HBsAg-positive Rheumatoid Arthritis Patients
Wooseong Jeong, Jung-Yoon Choe, Byung-Cheol Song, Chang-Keun Lee, Hoon-Suk Cha, Byeongzu Ghang, Jinseok Kim
The Open Rheumatology Journal.2021; 15(1): 39. CrossRef Case reports of latent HBV hepatitis in patients after neurosurgical treatment for hypothalamic and pituitary tumors
Kuniyasu Niizuma, Yoshikazu Ogawa, Takayuki Kogure, Teiji Tominaga
BMC Infectious Diseases.2020;[Epub] CrossRef Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B
Grace Lai‐Hung Wong, Becky Wing‐Yan Yuen, Henry Lik‐Yuen Chan, Yee‐Kit Tse, Terry Cheuk‐Fung Yip, Kelvin Long‐Yan Lam, Grace Chung‐Yan Lui, Vincent Wai‐Sun Wong, Francesco Negro
Liver International.2019; 39(2): 271. CrossRef Hepatitis B virus reactivation with corticosteroid therapy in patients with adrenal insufficiency
Masako Hatano, Toshihide Mimura, Akira Shimada, Mitsuhiko Noda, Shigehiro Katayama
Endocrinology, Diabetes & Metabolism.2019;[Epub] CrossRef A snapshot of virological presentation and outcome of immunosuppression‐driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection
Romina Salpini, Arianna Battisti, Luna Colagrossi, Domenico Di Carlo, Lavinia Fabeni, Lorenzo Piermatteo, Carlotta Cerva, Miriam Lichtner, Claudio Mastroianni, Massimo Marignani, Sarah Maylin, Constance Delaugerre, Filomena Morisco, Nicola Coppola, Aldo M
Journal of Viral Hepatitis.2019; 26(7): 846. CrossRef Hepatitis B virus-related mortality in rheumatoid arthritis patients undergoing long-term low-dose glucocorticoid treatment: A population-based study
Sheng-Shun Yang, Chin-Tun Hung, Shu-Fen Li, Horng-Mo Lee, Yueh-Chin Chung, Hsin-Hua Chen, Shu-Chuan Chang
Journal of the Formosan Medical Association.2018; 117(7): 566. CrossRef INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids
Anil Arora, Anil C. Anand, Ashish Kumar, Shivaram P. Singh, Rakesh Aggarwal, Radha K. Dhiman, Shyam Aggarwal, Seema Alam, Pradeep Bhaumik, Vinod K. Dixit, Ashish Goel, Bhabadev Goswami, Ashok Kumar, Manoj Kumar, Kaushal Madan, Natarajan Murugan, Aabha Nag
Journal of Clinical and Experimental Hepatology.2018; 8(4): 403. CrossRef Reactivation of Hepatitis B Virus and Its Prevention in Patients with Rheumatic Diseases Receiving Immunosuppressive Therapy
Eun-Jung Park, Kyu-sik Choi, Byung-Cheol Song
Journal of Rheumatic Diseases.2017; 24(5): 261. CrossRef Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)
Vincent Mallet, Florian van Bömmel, Christopher Doerig, Sven Pischke, Olivier Hermine, Anna Locasciulli, Catherine Cordonnier, Thomas Berg, Darius Moradpour, Heiner Wedemeyer, Per Ljungman
The Lancet Infectious Diseases.2016; 16(5): 606. CrossRef Treatment of rheumatic diseases and hepatitis B virus coinfection
Anna Felis-Giemza, Marzena Olesińska, Katarzyna Świerkocka, Ewa Więsik-Szewczyk, Ewa Haładyj
Rheumatology International.2015; 35(3): 385. CrossRef Treatment considerations in patients with concomitant viral infection and autoimmune rheumatic diseases
Worawit Louthrenoo
Best Practice & Research Clinical Rheumatology.2015; 29(2): 319. CrossRef Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues
Miguel Cordero-Coma, Raquel Salazar-Méndez, Taygan Yilmaz
Expert Opinion on Drug Safety.2015; 14(9): 1353. CrossRef Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis B virus infection: a retrospective cohort study
Mary Jane Burton, Jeffrey R Curtis, Shuo Yang, Lang Chen, Jasvinder A Singh, Ted R Mikuls, Kevin L Winthrop, John W Baddley
Arthritis Research & Therapy.2015;[Epub] CrossRef Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy
Pilar López-Serrano
World Journal of Hepatology.2015; 7(3): 539. CrossRef Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy—a report of long-term follow-up of serial cases and literature review
Dandan Xuan, Yiqi Yu, Linyun Shao, Jiali Wang, Wenhong Zhang, Hejian Zou
Clinical Rheumatology.2014; 33(4): 577. CrossRef Should We Consider Patients with Coexistent Hepatitis B or C Infection for Orthotopic Heart Transplantation?
Baskar Sekar, Pippa J. Newton, Simon G. Williams, Steven M. Shaw
Journal of Transplantation.2013; 2013: 1. CrossRef
|